XEN1701

N/A

Report date: 2025/12/05 16:14:40
NME

Base Information

Drug NameXEN1701
Drug Alias NameXEN-1701
ClassificationSmall molecules
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesXenon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A